543748 Stock Overview
Aarti Pharmalabs Limited primarily engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Aarti Pharmalabs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹511.30 |
| 52 Week High | ₹594.90 |
| 52 Week Low | ₹321.00 |
| Beta | 0 |
| 1 Month Change | 13.28% |
| 3 Month Change | -2.21% |
| 1 Year Change | 29.56% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 35.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543748 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -2.0% | 0.8% | 0.5% |
| 1Y | 29.6% | 58.6% | 44.7% |
Return vs Industry: 543748 underperformed the Indian Pharmaceuticals industry which returned 58.6% over the past year.
Return vs Market: 543748 underperformed the Indian Market which returned 44.7% over the past year.
Price Volatility
| 543748 volatility | |
|---|---|
| 543748 Average Weekly Movement | 5.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 9.9% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 543748 has not had significant price volatility in the past 3 months.
Volatility Over Time: 543748's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 2,042 | Hetal Gala | www.aartipharmalabs.com |
Aarti Pharmalabs Limited primarily engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates in India and internationally. Its APIs and intermediates are used in various therapeutic areas, including anti-hypertensive, anti-asthmatic, anti-cancer, central nervous system (CNS) agents, skincare, decongestant, cardiovascular, anti-thalassemic, analgesic, anti-diabetic, and ophthalmologic medications. The company also develops new chemical entities (NCE), regulatory starting materials (RSM), basic starting materials, key starting materials (KSM), key building blocks, xanthine derivatives, and allied products.
Aarti Pharmalabs Limited Fundamentals Summary
| 543748 fundamental statistics | |
|---|---|
| Market cap | ₹46.39b |
| Earnings (TTM) | ₹1.95b |
| Revenue (TTM) | ₹18.32b |
23.8x
P/E Ratio2.5x
P/S RatioIs 543748 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543748 income statement (TTM) | |
|---|---|
| Revenue | ₹18.32b |
| Cost of Revenue | ₹10.97b |
| Gross Profit | ₹7.34b |
| Other Expenses | ₹5.40b |
| Earnings | ₹1.95b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 13, 2024
| Earnings per share (EPS) | 21.46 |
| Gross Margin | 40.09% |
| Net Profit Margin | 10.62% |
| Debt/Equity Ratio | 13.1% |
How did 543748 perform over the long term?
See historical performance and comparison